Allurion Technologies Inc

NYSE:ALUR 3:59:50 PM EDT

0.65

-0.03 (-4.10%)

: $0.64 -0.01 (-1.03%)

Market Cap (Intraday)	41.89M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$8.73 Million
Adjusted EPS	-$0.16

See more estimates

10-Day MA	$0.65
50-Day MA	$0.82
200-Day MA	$2.12

See more pivots

Allurion Technologies Inc Stock, NYSE:ALUR

11 Huron Drive, Natick, Massachusetts 01760

United States of America

Phone: +1.508.647.4000

Number of Employees: 252

http://www.allurion.com

Description

Allurion Technologies, Inc. develops treatments for obesity. The Allurion Program is a weight loss platform that combines the Allurion Gastric Balloon, a swallowable, procedure-less gastric balloon for weight loss, the Allurion Virtual Care Suite including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform, and the Allurion Connected Scale and Health Tracker devices. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor and manage weight loss therapy for patients regardless of their treatment plan: gastric balloon, surgical, medical or nutritional. The company was founded on January 25, 2023 and is headquartered in Natick, MA.